I&I Biosimilars Marketing Director

Job description

Use Your Power for Purpose The US Commercial organization, which is in the Global Hospital & Biosimilars organization, is comprised of over 200 products, spanning more than 10 therapeutic areas, with annual revenue of over $2.5B. The US Commercial Biosimilars Portfolio is comprised of the combined Inflammation & Immunology (I&I) and Oncology biosimilars (BSM) portfolios, with net revenue of ~ $1B, within the US Commercial organization. This includes eight BSM assets - Abrilada, Inflectra, Nivestym, Nyvepria, Retacrit, Ruxience, Trazimera, Zirabev. The I&I Biosimilars Marketing Director is the P&L owner for the immunology portfolio comprised of 2 assets in Abrilada and Inflectra with wide indications that reach thousands of patients annually. This is a highly dynamic marketplace with multiple competitors and with diversified points of care and $400M+ in annual revenue. This role will report to the US Commercial Biosimilars Portfolio Lead and will interface extensively with cross-functional partners within Global Hospital & Biosimilars, US Market Access, and Pfizer Global Supply, among other functions. This position requires strong strategic, analytical and execution skills, interper...